Alterity completes Phase 2 trial in multiple system atrophy
[ad_1] Altality Therapeutics (ASX:ATH) announced the completion of a Phase 2 clinical trial of its lead drug candidate, ATH434, in multiple system atrophy (MSA). Although results have not been announced, Alterity expects to announce top-line results in late January or…
Salesforce soars 10% on Q3 earnings and AI advances
[ad_1] Salesforce (NYSE: CRM) stock soared more than 10% in after-hours trading following the company’s Q3 2025 earnings report. The company beat revenue expectations, raised its full-year revenue outlook and highlighted progress in its artificial intelligence (AI) efforts. The stock…
Amazon builds world’s largest supercomputer
[ad_1] Amazon Web Services (AWS) has announced plans to build what it claims is the world’s largest artificial intelligence (AI) supercomputer. The supercomputer, dubbed Project Rainier, is expected to be operational by 2025. The announcement was made at the AWS…
DroneShield (ASX:DRO) secures $8.2 million European defense contract
[ad_1] drone shield (ASX:DRO) announced $8.2 million worth of reorders from major military customers in Europe. The contract includes the provision of dismounted and vehicle-mounted counter-drone (Counter-UxS) systems, which are expected to be delivered within the next three months, including…
HMC Capital (ASX:HMC) acquires Neoen’s Victorian renewable energy portfolio for $950 million
[ad_1] HMC Capital takes another step into the energy transition sector by announcing the acquisition of Neoen’s Victorian renewable energy portfolio for $950 million. The portfolio includes 652MW of operating capacity across wind, solar and battery energy storage systems (BESS)…
INOVIQ completes breast cancer testing research
[ad_1] Innovic (ASX:IIQ) announced advances in its SubB2M diagnostic program and completed specificity studies for its “neuCA15-3” breast cancer monitoring test. This test is being developed to monitor treatment response and recurrence of breast cancer. This test is effective in…
Larvotto Resources secures $30 million in equity funding
[ad_1] Larbot resources (ASX:LRV) announced that it has successfully raised $30 million in equity by issuing 57.7 million new shares at $0.52 per share. The two-tranche offering received strong support from both existing and new institutional investors. This funding, along…
Spartan Resources raises $220 million
[ad_1] spartan resources (ASX:SPR) has secured $220 million in funding from institutional investors to accelerate the restart of operations at its Dalgalanga Gold Project in Western Australia. The offering was priced at $1.32 per share and received strong support from…
Mesoblast’s Revascor receives FDA approval, but stock price falls
[ad_1] mesoblast (ASX:MSB) announced that the U.S. Food and Drug Administration (FDA) has granted advanced regenerative therapy designation to Revascor (rexlemestrocel-L) for children with hypoplastic left heart syndrome (HLHS). This is based on the rare pediatric disease (RPD) and orphan…
Shell and Equinor to merge North Sea assets
[ad_1] Shell (LSE:SHEL) and Equinor (OSE:EQNR) have announced plans to combine their North Sea oil and gas assets to form a new company that will become one of the region’s largest producers. The joint venture will be based in Aberdeen….